Kimberly D. Anderson

The Interdisciplinary Stem Cell Institute’s Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental Cell Therapy to Patients With Rare Serious Diseases

B. Green, J. Guest, D. Yavagal, 2021, Frontiers in Cell and Developmental Biology.

Scalable culture techniques to generate large numbers of purified human Schwann cells for clinical trials in human spinal cord and peripheral nerve injuries

J. Guest, W. D. Dietrich, D. Pearse, 2021, Journal of neurosurgery. Spine.

Neurophysiological Changes in the First Year After Cell Transplantation in Sub-acute Complete Paraplegia

J. Guest, A. Levi, A. J. Santamaria, 2021, Frontiers in Neurology.

Phase 1 Safety Trial of Autologous Human Schwann Cell Transplantation in Chronic Spinal Cord Injury.

Christine K. Thomas, M. Nash, J. Guest, 2021, Journal of neurotrauma.

Development and deployment of an at-home strength and conditioning program to support a phase I trial in persons with chronic spinal cord injury

R. Cowan, K. Gant, Jennifer L Maher, 2020, Spinal Cord.

Development of a pain education resource for people with spinal cord injury

E. Widerström-Noga, G. Fernández, N. Cherup, 2023, Frontiers in public health.